A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
Year: 1999
Type: article
Source: PubMed
Authors: W Y Chen, P Ramamoorthy, N Chen, R Sticca, T E Wagner
Institution: Prisma Health
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2106837218
